Tanshinone IIA Prevents Uric Acid Nephropathy in Rats through NF-κB Inhibition

Xinlin Wu; Lihua Liu; Hongbo Xie; Jiantang Liao; Xin Zhou; Jianxin Wan; Kuang Yu; Junbiao Li; Yu Zhang

doi:10.1055/s-0031-1298487

Planta Medica, Table of Contents

Planta Med 2012; 78(09): 866-873
DOI: 10.1055/s-0031-1298487

Biological and Pharmacological Activity

Original Papers

Georg Thieme Verlag KG Stuttgart · New York

Tanshinone IIA Prevents Uric Acid Nephropathy in Rats through NF-κB Inhibition

Authors

Xinlin Wu^*

¹Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Lihua Liu^*

¹Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Hongbo Xie

¹Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Jiantang Liao

¹Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Xin Zhou

¹Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Jianxin Wan

¹Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Kuang Yu

¹Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Junbiao Li

¹Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Yu Zhang

¹Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

Abstract

The purpose of this research is to investigate the effect of tanshinone IIA, an extract of the Chinese medicine Que Xie Hua Yu Tang, on uric acid nephropathy (UAN) and to elucidate the underlying mechanisms. UAN rat model was established. Fifty UAN rats were randomly allocated into 5 groups: adenine-treated group, allopurinol-treated group, and low/middle/high dose of tanshinone IIA-treated groups. Meanwhile, another 10 rats were used as normal controls. Serum uric acid (UA), blood urea nitrogen (BUN), serum creatinine (Scr), MCP-1, and IL-1β levels were measured. Histological staining was performed. Comparison between the adenine group and treatment (allopurinol and tanshinone IIA) groups showed compound treatment could attenuate the inflammation status of the kidneys and decrease serum UA levels. Among different kinds of medicine, tanshinone IIA had similar effects as allopurinol and exerted anti-inflammatory and renal protective effect in a dose-dependent manner. Furthermore, we found tanshinone IIA alone could also inhibit urate-induced MCP-1 and IL-1β overexpression both in vivo and in vitro, accompanied with inhibition of NF-κB translocation from cytosome to nucleus. Tanshinone IIA could protect rats from uric acid-induced kidney damage, probably by attenuating renal inflammatory status.

Key words

tanshinone IIA - uric acid nephropathy - Chinese herb - Salvia miltiorrhiza - Lamiaceae

Full Text

References

References
1 Klemp P, Stansfield SA, Castle B, Robertson MC. Gout is on the increase in New Zealand. Ann Rheum Dis 1997; 56: 22-26
2 Arromdee E, Michet CJ, Crowson CS, OʼFallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising?. J Rheumatol 2002; 29: 403-406
3 Liote F. Hyperuricemia and gout. Curr Rheumatol Rep 2003; 5: 27-34
4 Zeng Q, Wang Q, Chen R, Xiao Z, Huang S, Xu J. Primary gout in Shantou: a clinical and epidemiological study. Chin Med J (Engl) 2003; 116: 6-9
5 Li Y, Stamler J, Xiao Z, Folsom A, Tao S, Zhang H. Serum uric acid and its correlates in Chinese adult populations, urban and rural, of Beijing. The PRC-USA collaborative study in cardiovascular and cardiopulmonary epidemiology. Int J Epidemiol 1997; 26: 88-96
6 Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. Is there a pathogenic role for uric acid in hypertension and cardiovascular and renal disease?. Hypertension 2003; 41: 1183-1190
7 Tseng CH. Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with type 2 diabetes. Diabet Med 2005; 21: 24-29
8 Marangella M. Uric acid elimination in the urine: pathophysiological implications. Contrib Nephrol 2005; 147: 32-48
9 Umekawa T, Chegini N, Khan SR. Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant 2003; 18: 664-669
10 Jaramillo M, Godbout M, Naccache PH, Olivier M. Signaling events involved in macrophage chemokine expression in response to monosodium urate crystals. J Biol Chem 2004; 279: 52797-52805
11 Reungjui S, Hu H, Mu W, Roncal CA, Croker BP, Patel JM, Nakagawa T, Srinivas T, Byer K, Simoni J, Wesson D, Sitprija V, Johnson RJ. Effect of elevated serum uric acid on cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 2007; 292: F116-F122
12 Stein TD, Johnson JA. Lack of neurodegeneration in transgenic mice overexpression mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J Neurosci 2002; 22: 7380-7388
13 Niu XL, Ichimori K, Yang X, Hirota Y, Hoshiai K, Li M, Nakazawa H. Tanshinone IIA inhibits low-density lipoprotein oxidation in vitro . Free Radic Res 2000; 33: 305-312
14 Wang AM, Sha AH, Lesniak W, Schacht J. Tanshinone. Salviae miltiorrhizae extract preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo . Antimicrob Agents Chemother 2003; 47: 1836-1841
15 Yu XY, Lin SG, Zhou ZW, Chen X, Liang J, Duan W, Yu XQ, Wen JY, Chowbay B, Li CG, Sheu FS, Chan E, Zhou SF. Tanshinone IIB, a primary active constituent from Salvia miltiorrhiza, exhibits neuro-protective activity in experimentally stroked rats. Neurosci Lett 2007; 417: 261-265
16 Zhou GY, Zhao BL, Hou JW, Ma GE, Xin WJ. Protective effects of sodium tanshinone IIA sulphonate against adriamycin-induced lipid peroxidation in mice hearts in vivo and in vitro . Pharmacol Res 1999; 40: 487-491
17 Wu XL, Li ZJ, Zhang WJ, Ao QX, Xu YW. Clinical study on Shen Shuai Fang in treating chronic renal failure. Zhong Yao Cai 2008; 31: 796-798
18 Martinon F. Mechanisms of uric acid crystal-mediated autoinflammation. Immunol Rev 2010; 233: 218-232
19 Richette P, Bardin T. Gout. Lancet 2010; 375: 318-328
20 Kubo A, Nishitani Y, Minamino N, Kikumoto K, Kurioka H, Nishino T, Iwano M, Shiiki H, Kangawa K, Dohi K. Adrenomedullin gene transcription is decreased in peripheral blood mononuclear cells of patients with IgA nephropathy. Nephron 2000; 85: 201-206
21 Umekawa T, Chegini N, Khan SR. Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant 2002; 18: 664-669
22 Kang D-H, Park SK, Lee IK, Johnson RJ. Uric acid induced C-reactive protein (CRP) expression: implication on cell proliferation and nitric oxide production in human vascular cells. J Am Soc Nephrol 2005; 16: 3553-3562
23 Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007; 293: 584-596
24 Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003; 41: 1287-1293
25 Viedt C, Orth SR. Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes?. Nephrol Dial Transplant 2002; 17: 2043-2207
26 Mu W, Ouyang X, Agarwal A. IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. J Am Soc Nephrol 2005; 16: 3651-3660
27 Mu W, Long DA, Ouyang X. Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism. Am J Physiol Renal Physiol 2009; 296: F145-F152
28 Ryu SY, No Z, Kim SH, Ahn JW. Two novel abietane diterpenes from Salvia miltiorrhiza . Planta Med 1997; 63: 44-46
29 Jang SI, Jeong SI, Kim KJ, Kim HJ, Yu HH, Park R, Kim HM, You YO. Tanshinone IIA from Salvia miltiorrhiza inhibits inducible nitric oxide synthase expression and production of TNF-α, IL-1β and IL-6 in activated RAW 264.7 cells. Planta Med 2003; 69: 1057-1059
30 Cho KH, Kim HJ, Rodriguez-Iturbe B, Vaziri ND. Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure. Am J Physiol Renal Physiol 2009; 297: F106-F113
31 Vaziri ND, Bai Y, Yuan J, Said HL, Sigala W, Ni Z. ApoA-1 mimetic peptide reverses uremia-induced upregulation of pro-atherogenic pathways in the aorta. Am J Nephrol 2010; 32: 201-211
32 Yoshida H, Imaizumi T, Tanji K, Sakaki H, Metoki N, Sato Y, Wakabayashi K, Kimura H, Satoh K. Interleukin-1beta enhances the angiotensin-induced expression of plasminogen activator inhibitor-1 through angiotensin receptor upregulation in human astrocytes. Brain Res 2006; 1073: 38-47